Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Zylox-Tonbridge Medical Technology Co Ltd
Capital Expenditures
Zylox-Tonbridge Medical Technology Co Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
|
Capital Expenditures
-¥190.9m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Capital Expenditures
-¥202m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Capital Expenditures
-¥97.5m
|
CAGR 3-Years
50%
|
CAGR 5-Years
26%
|
CAGR 10-Years
2%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Capital Expenditures
-¥2.1B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Capital Expenditures
-¥650.7m
|
CAGR 3-Years
9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-20%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Capital Expenditures
-¥1.1B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zylox-Tonbridge Medical Technology Co Ltd
Glance View
Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.
See Also
What is Zylox-Tonbridge Medical Technology Co Ltd's Capital Expenditures?
Capital Expenditures
-190.9m
CNY
Based on the financial report for Dec 31, 2024, Zylox-Tonbridge Medical Technology Co Ltd's Capital Expenditures amounts to -190.9m CNY.
What is Zylox-Tonbridge Medical Technology Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-36%
Over the last year, the Capital Expenditures growth was 0%. The average annual Capital Expenditures growth rates for Zylox-Tonbridge Medical Technology Co Ltd have been -29% over the past three years , -36% over the past five years .
You don't have any saved screeners yet